1. Immunotherapy in skin cancers - A narrative review
    V. T. Anjali et al, 2022, Journal of Skin and Sexually Transmitted Diseases CrossRef
  2. Methylation and mutation of the inhibin‑α gene in human melanoma cells and regulation of PTEN expression and AKT/PI3K signaling by a demethylating agent
    Hyunmin Ko et al, 2021, Oncology Reports CrossRef
  3. The Overexpression of SLC25A13 Predicts Poor Prognosis and Is Correlated with Immune Cell Infiltration in Patients with Skin Cutaneous Melanoma
    Yue lv et al, 2022, Disease Markers CrossRef
  4. Gene signatures of 6-methyladenine regulators in women with lung adenocarcinoma and development of a risk scoring system: a retrospective study using the cancer genome atlas database
    Chundi Gao et al, 2021, Aging CrossRef
  5. Biomarkers Associated with Immune-Related Adverse Events under Checkpoint Inhibitors in Metastatic Melanoma
    Marcus Wölffer et al, 2022, Cancers CrossRef
  6. Retrospective Analysis of Neutrophil-to-Lymphocyte Ratio in Patients with Melanoma Who Received Ipilimumab Monotherapy or Ipilimumab in Combination with Nivolumab in Japan
    Yuka Matsumura et al, 2023, Biological and Pharmaceutical Bulletin CrossRef
  7. A Novel Necroptosis-Related Gene Signature in Skin Cutaneous Melanoma Prognosis and Tumor Microenvironment
    Binyu Song et al, 2022, Frontiers in Genetics CrossRef
  8. Landscape and Clinical Significance of Immune Checkpoint in Cutaneous Melanoma
    Rui Mao et al, 2021, Frontiers in Immunology CrossRef
  9. Advances in the discovery and development of melanoma drug therapies
    Monica Chanda et al, 2021, Expert Opinion on Drug Discovery CrossRef
  10. Predictive and Prognostic Value of BRAF and NRAS Mutation of 159 Sentinel Lymph Node Cases in Melanoma—A Retrospective Single-Institute Study
    Gabriella Liszkay et al, 2021, Cancers CrossRef
  11. Novel Therapeutic Approaches with DNA Damage Response Inhibitors for Melanoma Treatment
    Luisa Maresca et al, 2022, Cells CrossRef
  12. Indoleamine 2, 3-Dioxygenase: A Professional Immunomodulator and Its Potential Functions in Immune Related Diseases
    Fahimeh Heidari et al, 2022, International Reviews of Immunology CrossRef
  13. Ruthenium and iridium complexes bearing porphyrin moieties: PDT efficacy against resistant melanoma cells
    Nuno M.M. Moura et al, 2022, Dyes and Pigments CrossRef
  14. The Role of Senescent Cells in Acquired Drug Resistance and Secondary Cancer in BRAFi-Treated Melanoma
    Elizabeth L. Thompson et al, 2021, Cancers CrossRef
  15. Cancer Management during COVID-19 Pandemic: Is Immune Checkpoint Inhibitors-Based Immunotherapy Harmful or Beneficial?
    Silvia Vivarelli et al, 2020, Cancers CrossRef
  16. MicroRNA-Mediated Antiproliferative Effects of M1 Macrophage-Derived Extracellular Vesicles on Melanoma Cells
    Najla Adel Saleh et al, 2024, Immunological Investigations CrossRef
  17. Selective therapeutic benefit of X-rays and inhibitors of EGFR, PI3K/mTOR, and Bcl-2 in breast, lung, and cervical cancer cells
    Mogammad Baaghith Hamid et al, 2021, European Journal of Pharmacology CrossRef
  18. IFN-γ and TNF Induce Senescence and a Distinct Senescence-Associated Secretory Phenotype in Melanoma
    Lorenzo Homann et al, 2022, Cells CrossRef
  19. Melanoma stem cell vaccine induces effective tumor immunity against melanoma
    Qiliang Yin et al, 2023, Human Vaccines & Immunotherapeutics CrossRef
  20. A new ferroptosis-related genetic mutation risk model predicts the prognosis of skin cutaneous melanoma
    Jia He et al, 2023, Frontiers in Genetics CrossRef
  21. USP35 is a Potential Immunosuppressive Factor in Skin Cutaneous Melanoma
    Qian Zhang et al, 2022, Journal of Inflammation Research CrossRef
  22. Long non-coding RNA CCHE1 modulates LDHA-mediated glycolysis and confers chemoresistance to melanoma cells
    Zhi Ding et al, 2023, Cancer & Metabolism CrossRef
  23. Cytotoxic and Antioxidant Activity of Hypericum perforatum L. Extracts against Human Melanoma Cells from Different Stages of Cancer Progression, Cultured under Normoxia and Hypoxia
    Aleksandra Brankiewicz et al, 2023, Molecules CrossRef
  24. Role of Biomarkers in the Integrated Management of Melanoma
    Piyu Parth Naik et al, 2021, Disease Markers CrossRef
  25. In vitro anti-melanoma activity of imiquimod in ultradeformable nanovesicles
    Ayelen Tatiana Caimi et al, 2022, Drug Development and Industrial Pharmacy CrossRef
  26. Companion Animal Model in Translational Oncology; Feline Oral Squamous Cell Carcinoma and Canine Oral Melanoma
    Antonio Giuliano, 2021, Biology CrossRef
  27. Transcriptomic profiling and classification of skin melanoma based on ultraviolet response
    Dongxing Xiao* et al, 2023, Dermatologica Sinica CrossRef
  28. Exploring the impact of deubiquitination on melanoma prognosis through single-cell RNA sequencing
    Su Peng et al, 2024, Frontiers in Genetics CrossRef
  29. Genomics and Epigenomics in the Molecular Biology of Melanoma—A Prerequisite for Biomarkers Studies
    Daniela Luminita Zob et al, 2022, International Journal of Molecular Sciences CrossRef
  30. Myositis/Myasthenia after Pembrolizumab in a Bladder Cancer Patient with an Autoimmunity-Associated HLA: Immune–Biological Evaluation and Case Report
    Cirino Botta et al, 2021, International Journal of Molecular Sciences CrossRef
  31. Review of the Immune Checkpoint Inhibitors in the Context of Cancer Treatment
    Norah A. Alturki, 2023, Journal of Clinical Medicine CrossRef
  32. Advanced Acral Melanoma Therapies: Current Status and Future Directions
    Yiqun Zhang et al, 2022, Current Treatment Options in Oncology CrossRef
  33. Dermoscopic Criteria, Histopathological Correlates and Genetic Findings of Thin Melanoma on Non-Volar Skin
    Cesare Massone et al, 2021, Genes CrossRef
  34. Dynamic Changes in Circulating Tumor Fraction as a Predictor of Real-World Clinical Outcomes in Solid Tumor Malignancy Patients Treated with Immunotherapy
    Ryan D. Gentzler et al, 2024, Oncology and Therapy CrossRef
  35. Advances in Targeting Cutaneous Melanoma
    Dimitri Kasakovski et al, 2021, Cancers CrossRef
  36. Pyroptosis-Related Lncrna Prognostic Signatures for Cutaneous Melanoma and Tumor Microenvironment Status
    Huiling Deng et al, 2023, Epigenomics CrossRef
  37. In Vitro and In Ovo Assessment of Betulinic Acid Antimelanoma Effect
    Dorina Coricovac et al, 2020, Timisoara Medical Journal CrossRef
  38. Ferroptosis-Related Gene Signature Predicts the Prognosis of Skin Cutaneous Melanoma and Response to Immunotherapy
    Ziqian Xu et al, 2021, Frontiers in Genetics CrossRef
  39. C‐reactive protein flare predicts response to checkpoint inhibitor treatment in melanoma
    Julian Kött et al, 2024, Journal of the European Academy of Dermatology and Venereology CrossRef
  40. Identification of Immune Cell Infiltration Landscape and Their Prognostic Significance in Uveal Melanoma
    Han Zhao et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
  41. Synergistic Action of Immunotherapy and Nanotherapy against Cancer Patients Infected with SARS-CoV-2 and the Use of Artificial Intelligence
    Tanvi Gupta et al, 2022, Cancers CrossRef
  42. Identification of subtypes correlated with tumor immunity and immunotherapy in cutaneous melanoma
    Qian Liu et al, 2021, Computational and Structural Biotechnology Journal CrossRef
  43. Promising prognostic value of Transglutaminase type 2 and its correlation with tumor-infiltrating immune cells in skin cutaneous melanoma
    Silvia Muccioli et al, 2022, Cell Death Discovery CrossRef
  44. Adjuvant Therapy for High-Risk Stage II Melanoma: Current Paradigms in Management and Future Directions
    Gracia Maria Vargas et al, 2024, Cancers CrossRef
  45. Prognostic Value of Lymphocyte-to-Monocyte Ratio (LMR) in Cancer Patients Undergoing Immune Checkpoint Inhibitors
    Luying Wan et al, 2022, Disease Markers CrossRef
  46. 1,4-dihydroxy quininib modulates the secretome of uveal melanoma tumour explants and a marker of oxidative phosphorylation in a metastatic xenograft model
    Kayleigh Slater et al, 2023, Frontiers in Medicine CrossRef
  47. Melanoma therapeutics: a literature review
    Pavan Kumar Dhanyamraju et al, 2022, The Journal of Biomedical Research CrossRef
  48. A Necroptosis-Related Gene Signature to Predict the Prognosis of Skin Cutaneous Melanoma
    Yihui Xie et al, 2022, Disease Markers CrossRef
  49. PGAM5: A necroptosis gene associated with poor tumor prognosis that promotes cutaneous melanoma progression
    Jianzhong Peng et al, 2022, Frontiers in Oncology CrossRef
  50. KMT2C is a Potential Biomarker of Anti-PD-1 Treatment Response in Metastatic Melanoma
    Kuixia Xie et al, 2022, Frontiers in Bioscience-Landmark CrossRef
  51. Tumour Suppressor Neuron Navigator 3 and Matrix Metalloproteinase 14 are Co-expressed in Most Melanomas but Downregulated in Thick Tumours
    Olga Bugaeva et al, 2023, Acta Dermato-Venereologica CrossRef
  52. Essential Oils and Their Main Chemical Components: The Past 20 Years of Preclinical Studies in Melanoma
    Marta Di Martile et al, 2020, Cancers CrossRef
  53. Immunotherapy in Acral and Mucosal Melanoma: Current Status and Future Directions
    Lili Mao et al, 2021, Frontiers in Immunology CrossRef
  54. Epigenetic Regulation in Melanoma: Facts and Hopes
    Emilio Francesco Giunta et al, 2021, Cells CrossRef
  55. Demographics, Pattern of Care, and Outcome Analysis of Malignant Melanomas - Experience From a Tertiary Cancer Centre in India
    Jyoti Bajpai et al, 2021, Frontiers in Oncology CrossRef
  56. NEDD4 E3 ubiquitin protein ligase serves an important role in cutaneous melanoma occurrence and development
    Fang Cheng et al, 2021, Experimental and Therapeutic Medicine CrossRef
  57. Identification and validation of a ferroptosis‐related gene signature for predicting survival in skin cutaneous melanoma
    Shuai Ping et al, 2022, Cancer Medicine CrossRef
  58. Cancer cell membrane-camouflaged and H2O2-activatable nanocomposites for synergistic chemotherapy and two-photon photodynamic therapy against melanoma
    Siyuan Gao et al, 2023, Inorganic Chemistry Frontiers CrossRef
  59. A novel risk model based on cuproptosis-related lncRNAs predicted prognosis and indicated immune microenvironment landscape of patients with cutaneous melanoma
    Yi Zhou et al, 2022, Frontiers in Genetics CrossRef
  60. Galbanic acid suppresses melanoma cell migration and invasion by reducing MMP activity and downregulating N-cadherin and fibronectin
    Masoumeh Azad et al, 2024, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
  61. Tumor-infiltrating macrophage associated lncRNA signature in cutaneous melanoma: implications for diagnosis, prognosis, and immunotherapy
    Qi Wan et al, 2024, Aging CrossRef
  62. Exploring a specialized programmed-cell death patterns to predict the prognosis and sensitivity of immunotherapy in cutaneous melanoma via machine learning
    Leyang Xiao et al, 2024, Apoptosis CrossRef
  63. Intratumoral Microbiota: Insights from Anatomical, Molecular, and Clinical Perspectives
    Claudia Lombardo et al, 2024, Journal of Personalized Medicine CrossRef
  64. miRNA and mRNA expression profiling reveals potential biomarkers for metastatic cutaneous melanoma
    Jun Wang et al, 2021, Expert Review of Anticancer Therapy CrossRef
  65. HLA-DRB1: A new potential prognostic factor and therapeutic target of cutaneous melanoma and an indicator of tumor microenvironment remodeling
    Huiling Deng et al, 2022, PLOS ONE CrossRef

  66. Development and Validation of an Immune-Related Gene Pair Signature in Skin Cutaneous Melanoma


    Ran Xie et al, 2020, Clinical, Cosmetic and Investigational Dermatology CrossRef
  67. Comprehensive insights on genetic alterations and immunotherapy prognosis in Chinese melanoma patients
    Dong-Dong Jia et al, 2024, Scientific Reports CrossRef
  68. Melanoma Stem Cell Vaccine Activates Antitumor Immunity by Acting on CD8+T Cells in Multiple Facets
    Qiliang Yin et al, SSRN Electronic Journal CrossRef
  69. Introductory Chapter: Melanoma and Therapeutic Perspectives
    Karine Cohen Solal et al, 2021, Melanoma CrossRef
  70. Identification of an anoikis-related gene signature and characterization of immune infiltration in skin cutaneous melanoma
    Ziqian Xu et al, 2024, Medicine CrossRef
  71. Current Trends of Immunotherapy in the Treatment of Cutaneous Melanoma: A Review
    Piyu Parth Naik, 2021, Dermatology and Therapy CrossRef
  72. Treatment‐resistant bullous pemphigoid developing during therapy with immune checkpoint inhibitors
    E. Povilaityte et al, 2021, Journal of the European Academy of Dermatology and Venereology CrossRef
  73. Peptide Vaccines in Melanoma: Chemical Approaches towards Improved Immunotherapeutic Efficacy
    Beáta Biri-Kovács et al, 2023, Pharmaceutics CrossRef
  74. Cutaneous Toxicities of Advanced Treatment for Cutaneous Melanoma: A Prospective Study from a Single-Center Institution
    Federico Venturi et al, 2024, Cancers CrossRef
  75. The Cytomorphology of Melanoma with a Special Emphasis on the Immune Checkpoint Proteins CTLA-4, PD-1, and PD-L1
    Markus Tiemann et al, 2023, Nature Cell and Science CrossRef
  76. PARP Inhibitors in Melanoma—An Expanding Therapeutic Option?
    Wei Yen Chan et al, 2021, Cancers CrossRef
  77. TNFRSF1B Gene Variants in Clinicopathological Aspects and Prognosis of Patients with Cutaneous Melanoma
    Bruna Fernandes Carvalho et al, 2024, International Journal of Molecular Sciences CrossRef
  78. The PIK3CA H1047R Mutation Confers Resistance to BRAF and MEK Inhibitors in A375 Melanoma Cells through the Cross-Activation of MAPK and PI3K–Akt Pathways
    Saverio Candido et al, 2022, Pharmaceutics CrossRef
  79. Comprehensive Review on the Clinical Relevance of Long Non-Coding RNAs in Cutaneous Melanoma
    Vincenzo De Falco et al, 2021, International Journal of Molecular Sciences CrossRef
  80. Exploration and validation of metastasis-associated genes for skin cutaneous melanoma
    Hong Luan et al, 2022, Scientific Reports CrossRef